InvestorsHub Logo
Followers 2
Posts 506
Boards Moderated 0
Alias Born 12/23/2014

Re: None

Wednesday, 04/18/2018 11:22:29 AM

Wednesday, April 18, 2018 11:22:29 AM

Post# of 128547
Read this in the local paper this morning. Reported by the Associated Press. There's a hearing on Thursday. This could be a final blow to the U.S. DEA holding to the right-wing fantasy that there is no medicinal value. Maybe tomorrow will be a big day. Just in time for 4-20!

WASHINGTON (AP) — A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

British drugmaker GW Pharmaceuticals is seeking permission to sell its purified form of an ingredient found in cannabis — one that doesn't get users high — as a medication for rare, hard-to-treat seizures in children. If successful, the company's liquid formula would be the first government-approved drug derived from the cannabis plant in the U.S.

The Food and Drug Administration's approval would technically limit the treatment to a small group of epilepsy patients. But doctors would have the option to prescribe it for other uses and it could spur new pharmaceutical research and interest into other cannabis-based products. Man-made versions of a different marijuana ingredient have previously been approved for other purposes.

The FDA posted its review of the experimental medication Epidiolex ahead of a public meeting Thursday when a panel of outside experts will vote on the medicine's safety and effectiveness. It's a non-binding recommendation that the FDA will consider in its final decision by late June.